Ageing vs. Disease
The relationship between ageing and disease is one of the most debated topics in biomedical science. Traditionally, medicine has drawn a sharp line between "natural" ageing and specific pathology. In this view, ageing is an inevitable, physiological decline that happens to everyone, while disease is a deviation from normal function that happens to some. However, as our understanding of molecular biology deepens, this distinction is becoming increasingly blurred. Recent reviews frame ageing as a gradual pathophysiological process that elevates risk across many disease categories, and biological ageing measures increasingly predict disease onset across systems. [1] [2]
Ageing as a Risk Factor
It is undisputed that age is the primary risk factor for the world's leading killers: heart disease, cancer, neurodegenerative disorders (like Alzheimer's), and type 2 diabetes. The correlation is exponential; for many of these conditions, risk rises steeply with advancing age, and large prospective cohorts emphasize age as the dominant determinant of degenerative disease risk. [1] [3]
This has led to the "Geroscience Hypothesis": the idea that the underlying molecular mechanisms of ageing (like inflammation and DNA damage) are the root causes of these diverse diseases. From this perspective, these diseases are late-stage manifestations of the ageing process itself. Treating them one by one is like playing "whack-a-mole"—curing one often leaves the patient vulnerable to another because the underlying biological terrain (the aged body) remains damaged. Studies linking accelerated biological age to higher incidence of specific diseases (such as rheumatoid arthritis and osteoarthritis) provide concrete examples of this shared-mechanism model. [2] [4] [5]
Multimorbidity
A key feature of ageing populations is multimorbidity—the presence of two or more chronic conditions in the same individual. It is rare for an elderly individual to have only heart disease or only arthritis. They often cluster together. This clustering supports the view that these are not independent events but shared symptoms of systemic biological decline, consistent with reviews that map multiple diseases to common ageing mechanisms. [1] [2]
The Debate: Is Ageing Itself a Disease?
This question is not just semantic; it has regulatory and medical implications.
Arguments Against Classifying Ageing as Disease
Historically, "disease" implies a chaotic or abnormal state. Since ageing is universal (it happens to every human), natural, and inevitable, many argue it cannot be a disease. Labifying it as such could pathologize the entire human experience of growing older, leading to ageism and the medicalization of a natural life stage.
Arguments For Classifying Ageing as Disease
Proponents argue that ageing fits the definition of disease: it is a harmful physiological process that leads to suffering, functional impairment, and death. Recognizing it as a treatable condition (or at least a targetable set of mechanisms) could unlock regulatory pathways (like FDA approval) for drugs designed to target ageing processes directly, rather than just specific downstream symptoms. The World Health Organization's inclusion of "ageing-related" codes in ICD-11 reflects a shift toward recognizing this biological reality. [6]
Clinical vs. Biological Definitions
In the clinic, doctors treat diagnoses. If you have high blood pressure, you get an antihypertensive. If you have high blood sugar, you get insulin. Currently, there is no diagnosis for "accelerated ageing" or "frailty" that triggers a prescription to slow the ageing process, though this is an active area of research. Biological age measures built from clinical biomarkers can capture risk beyond chronological age, but they are not yet standard clinical thresholds. [4] [5]
Biologically, the mechanism is the same. The arterial stiffening that causes "normal" age-related blood pressure increases is the same process that, when advanced, causes hypertension. The difference is often just an arbitrary threshold set by medical bodies to determine when to intervene, which is why biological age can identify higher-risk individuals before they cross a diagnostic line. [4]
Current Conclusions
- Ageing biology predicts disease: Composite biological ageing measures are linked to earlier onset of multiple age-related conditions and reduced life expectancy. [2] [4] [5]
- Shared mechanisms drive multimorbidity: Molecular hallmarks of ageing help explain why chronic diseases cluster in older adults. [1]
- Ageing is increasingly encoded in policy and classification: ICD-11 includes ageing-related modifiers, reflecting a shift toward formal recognition of ageing processes in disease coding. [6]
What Is Still Debated
- Disease vs. risk factor: Whether ageing should be labeled a disease remains a philosophical and regulatory debate, despite agreement on its harmful biological effects. [1]
- Clinical thresholds for "accelerated ageing": There is no consensus on which biological age measures should trigger intervention, or how they should be validated across populations. [4] [5]
- Intervention targets: Which ageing mechanisms are safest and most effective to target in humans remains unsettled, even as evidence accumulates that modifying ageing biology impacts multiple diseases. [1] [2]
Summary
Whether one labels ageing as a disease or a risk factor, the biological reality is that ageing and chronic disease are inextricably linked. They share the same molecular drivers. Understanding this connection is shifting the paradigm from reactive disease care (treating the sick) to proactive geroscience (maintaining health by targeting the biology of ageing). [1] [2]
This content is provided for educational purposes only and does not constitute medical advice.
References
- Guo, J., Huang, H. et al. "Aging and aging-related diseases: from molecular mechanisms to interventions." Signal Transduction and Targeted Therapy (2022). https://www.nature.com/articles/s41392-022-01251-0
- Fraser, H. C. et al. "Biological mechanisms of aging predict age-related disease onset." Communications Biology (2022). https://pmc.ncbi.nlm.nih.gov/articles/PMC9009120/
- UK Biobank. "Prospective studies of ageing and age-related diseases." https://www.ukbiobank.ac.uk/projects/prospective-studies-of-ageing-and-age-related-diseases/
- Chen, L. et al. "Associations between biological ageing and the risk of, and reduced life expectancy in, rheumatoid arthritis." The Lancet Healthy Longevity (2024). https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00220-9/fulltext
- He, Q. et al. "The association between accelerated biological aging and osteoarthritis." Frontiers in Public Health (2024). https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1451737/full
- WHO ICD-11 ageing-related coding discussed in: He, Q. et al. Frontiers in Public Health (2024). https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1451737/full